The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

Diabetologie und Stoffwechsel 2021; 16(S 01): S4-S5
DOI: 10.1055/s-0041-1727304

01. Klinische Diabetologie

LE Garcia-Pérez

¹Lilly, S.A., Medical, Alcobendas, Spain

,

H Sapin

²Lilly France SAS, Medical, Neuilly Sur Seine, France

,

K Norrbacka

³Eli Lilly and Company, Medical, Helsinki, Finland

,

B Guerci

⁴Hôpital Brabois Adultes, Medical, CHRU de Nancy, France

,

F Giorgino

⁵University of Bari, Medical, Aldo Moro, Italy

,

U Aigner

⁶Versdias GmbH, Medical, Sulzbach-Rosenberg, Germany

,

MO Federici

⁷Eli Lilly Company Italia SpA, Medical, Florence, Italy

,

R Gentilella

⁸Former employee of Eli Lilly Company Italia SpA, Medical, Florence, Italy

,

E Heitmann

⁹Lilly Deutschland GmbH, Medical, Bad Homburg, Germany

,

H Jung

⁹Lilly Deutschland GmbH, Medical, Bad Homburg, Germany

,

M Rosilio

²Lilly France SAS, Medical, Neuilly Sur Seine, France

,

K Boye

¹⁰Eli Lilly and Company, Medical, Indianapolis, United States